Midlothian, United Kingdom

A John Clark


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: A John Clark: Innovator in Genetic Engineering

Introduction

A John Clark is a notable inventor based in Midlothian, GB, recognized for his contributions to genetic engineering. He holds 2 patents that focus on advancing cloning technologies and improving transplant compatibility.

Latest Patents

His latest patents include innovative technologies such as telomerizing nuclear donor cells and enhancing the efficiency of nuclear transfer. The first patent provides a system for creating cloned cells and embryos that are genetically modified. This technology allows for the treatment of cells to increase the expression of telomerase, potentially extending their replicative capacity. Genetic modifications can be made to inactivate specific genes or confer desirable features, enabling the growth and selection of cells as needed. The modified nucleus can then be transferred to a suitable recipient cell, facilitating the development of embryos with the desired attributes.

The second patent focuses on generating animal tissue with carbohydrate antigens that are compatible for transplantation into human patients. This invention involves inactivating the expression of α(1,3)galactosyltransferase and incorporating a transgene for α(1,2)fucosyltransferase. As a result, the cell-surface N-acetyl lactosamine is converted to Fucα(1,2)Gal, which is a self-antigen in humans. This technology significantly improves the transplant compatibility of xenograft tissue by reducing the risk of adverse reactions.

Career Highlights

Throughout his career, A John Clark has worked with prominent organizations such as Geron Corporation and the Roslin Institute in Edinburgh. His work has significantly impacted the fields of cloning and transplantation.

Collaborations

He has collaborated with notable colleagues, including Chris Denning and J. Michael Schiff, contributing to advancements in genetic research and technology.

Conclusion

A John Clark's innovative work in genetic engineering has paved the way for significant advancements in cloning and transplantation technologies. His contributions continue to influence the field and enhance the compatibility of transplant procedures.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…